lysophosphatidic acid has been researched along with Liver Neoplasms in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 15 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agosti, P; Gigante, I; Lopane, C; Mazzocca, A; Sabbà, C | 1 |
| Chen, X; Chen, YX; Ding, G; He, J; Jin, L; Li, X; Lou, L; Tao, X; Wu, S; Ye, W; Zhu, J | 1 |
| Liu, XJ; Lv, LX; Wang, Q; Yang, P; Zhang, GD; Zhang, L; Zhao, M; Zhu, Y | 1 |
| Ahrens, WA; Iannitti, DA; Mckillop, IH; Showlater, V; Sokolov, E; Swet, JH; Zuckerman, V | 1 |
| Ahmad, NB; Baba, H; Bain, G; Baumert, TF; Beppu, T; Bian, CB; Chuang, WL; Chung, RT; Colombo, M; Dai, CY; El-Abtah, M; Erstad, DJ; Friedman, SL; Fuchs, BC; Ghoshal, S; Goossens, N; Gunasekaran, G; Higashi, T; Hoshida, H; Hoshida, Y; Iavarone, M; Kim, RS; Kobayashi, M; Koh, AP; Kumada, H; Lanuti, M; Lauwers, GY; Lee, Y; Llovet, JM; Mahajan, M; Nair, VD; Nakagawa, S; Sangiovanni, A; Schwarz, ME; Song, WM; Subramanian, A; Sun, X; Tager, AM; Tanabe, KK; Venkatesh, A; Villanueva, A; Wei, L; Yamada, S; Yu, ML; Zhang, B | 1 |
| Maluccio, MA; Scott, RE; Skill, NJ; Wu, J | 1 |
| Han, JW; Jeong, KJ; Kang, J; Kim, JM; Lee, HY; Lee, J; Lee, JS; Mills, GB; Panupinthu, N; Park, CG; Park, SY; Yu, S | 1 |
| Huang, X; Huang, Z; Pan, X; Zhang, G; Zhang, R; Zhang, Z | 1 |
| Fukushima, N; Hayashi, M; Honoki, K; Mori, T; Okabe, K; Teranishi, M; Tsujiuchi, T; Yamawaki, Y | 1 |
| Antonaci, S; Dituri, F; Giannelli, G; Lupo, L; Mazzocca, A; Quaranta, M | 1 |
| Deng, AM; Wu, SS; Xia, Q; Zheng, M | 1 |
| Fan, F; Ma, YG; Shi, S; Yao, ZZ; Zhu, B | 1 |
| Jianmin, W; Maluccio, MA; Skill, NJ; Tector, AJ; Yan, X; Zhao, Z | 1 |
| Ahrens, WA; Eheim, AL; McKillop, IH; McMillan, MT; Simo, KA; Sindram, D; Sokolov, E; Swet, JH; Thompson, KJ; Walling, TL | 1 |
| Maluccio, M; Skill, N; Wu, J; Xu, Y; Zhao, Z | 1 |
| Dou, KF; Li, KZ; Song, ZS; Wang, DS; Zhao, QC | 1 |
| Akedo, H; Itoh, K; Matsumura, F; Yoshioka, K | 1 |
| Akedo, H; Imamura, F; Iwasaki, T; Mukai, M; Nakamura, H; Tatsuta, M; Togawa, A | 1 |
1 review(s) available for lysophosphatidic acid and Liver Neoplasms
| Article | Year |
|---|---|
Implications of the lysophosphatidic acid signaling axis in liver cancer.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lysophospholipids; Phospholipids; Risk Factors; Signal Transduction | 2017 |
17 other study(ies) available for lysophosphatidic acid and Liver Neoplasms
| Article | Year |
|---|---|
Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor.
Topics: Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Receptors, Lysophosphatidic Acid | 2013 |
Alkylglyceronephosphate synthase (AGPS) alters lipid signaling pathways and supports chemotherapy resistance of glioma and hepatic carcinoma cell lines.
Topics: Alkyl and Aryl Transferases; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; beta Catenin; Carcinoma, Hepatocellular; Caspase 3; Caspase 8; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dinoprostone; Drug Resistance, Neoplasm; Glioma; Hep G2 Cells; Humans; Inhibitor of Apoptosis Proteins; Lipid Metabolism; Liver Neoplasms; Lysophospholipids; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptors, Lysophosphatidic Acid; RNA Interference; RNA, Small Interfering; Signal Transduction; Survivin | 2014 |
Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Hep G2 Cells; Humans; Liver Neoplasms; Lysophospholipids; Male; Middle Aged; Neoplastic Stem Cells; Receptors, Lysophosphatidic Acid; RNA Interference; RNA, Small Interfering; Signal Transduction | 2016 |
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Profiling; Gene Regulatory Networks; Genetic Predisposition to Disease; Humans; Liver Cirrhosis; Liver Neoplasms; Lysophospholipids; Rats; Risk Factors; Signal Transduction; Xenograft Model Antitumor Assays | 2016 |
Hepatocellular carcinoma associated lipid metabolism reprogramming.
Topics: Bile; Carcinoma, Hepatocellular; Case-Control Studies; Choline; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lipid Metabolism; Liver; Liver Neoplasms; Lysophosphatidylcholines; Lysophospholipids; Phospholipids; Receptors, G-Protein-Coupled | 2011 |
Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lysophospholipids; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Receptors, Lysophosphatidic Acid; Signal Transduction | 2011 |
ATX-LPA axis induces expression of OPN in hepatic cancer cell SMMC7721.
Topics: Blotting, Western; Cell Movement; Humans; Liver Neoplasms; Lysophospholipids; Multienzyme Complexes; Osteopontin; Phosphatidylinositol 3-Kinase; Phosphodiesterase I; Phosphoric Diester Hydrolases; Proto-Oncogene Proteins c-akt; Pyrophosphatases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Tumor Cells, Cultured | 2011 |
Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Methylation; Gene Expression Regulation, Neoplastic; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Lysophospholipids; Mutation; Neoplasms; Rats; Receptors, Lysophosphatidic Acid | 2011 |
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts.
Topics: Actins; Carcinoma, Hepatocellular; Cell Differentiation; Disease Progression; Fibroblasts; Humans; Liver Neoplasms; Lysophospholipids; Myofibroblasts; Phosphoric Diester Hydrolases | 2011 |
Cholera toxin inhibits human hepatocarcinoma cell proliferation in vitro via suppressing ATX/LPA axis.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cholera Toxin; Humans; Liver Neoplasms; Lysophospholipids; Phosphoric Diester Hydrolases | 2011 |
Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.
Topics: Blotting, Western; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Humans; Liver Neoplasms; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction | 2012 |
Lysophospholipid variants in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fatty Liver; Hepatitis C; Humans; Liver Neoplasms; Liver Transplantation; Lysophospholipids; Mass Spectrometry; Non-alcoholic Fatty Liver Disease; Receptors, Lysophosphatidic Acid; RNA, Messenger; Tumor Necrosis Factor-alpha | 2013 |
Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Female; Humans; Liver Neoplasms; Lysophospholipids; Male; Middle Aged; Receptors, Lysophosphatidic Acid; RNA, Messenger | 2013 |
Lysophosphatidic acid aberrancies and hepatocellular carcinoma: studies in the MDR2 gene knockout mouse.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Cell Transformation, Neoplastic; Drug Resistance, Multiple; Liver Neoplasms; Liver Neoplasms, Experimental; Lysophospholipids; Mice; Mice, Knockout; Phosphodiesterase Inhibitors; Phospholipids; Phosphoric Diester Hydrolases; Receptors, Lysosphingolipid; Signal Transduction | 2013 |
[Enhancement of invasion of hepatocellular carcinoma cells by lysophosphatidic acid through Rho signal transduction pathway].
Topics: Blotting, Western; Cell Line, Tumor; Cell Movement; Humans; Liver Neoplasms; Lysophospholipids; Neoplasm Invasiveness; rho GTP-Binding Proteins; Signal Transduction | 2006 |
Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells.
Topics: Actomyosin; ADP Ribose Transferases; Animals; Botulinum Toxins; Carcinoma, Hepatocellular; Epithelial Cells; GTP-Binding Proteins; Humans; Liver Neoplasms; Lysophospholipids; Mesentery; Models, Biological; Myosin Light Chains; Neoplasm Invasiveness; Phosphorylation; Rats; rhoA GTP-Binding Protein; Signal Transduction; Tumor Cells, Cultured | 1998 |
Hepatoma cell migration through a mesothelial cell monolayer is inhibited by cyclic AMP-elevating agents via a Rho-dependent pathway.
Topics: Animals; Bucladesine; Carcinoma, Hepatocellular; Cell Movement; Cyclic AMP; Drug Interactions; Epithelium; Liver Neoplasms; Lysophospholipids; Neoplasms, Mesothelial; Rats; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Tumor Cells, Cultured | 2000 |